Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PCSK9
Pharma
FDA endorses LIB's convenient cholesterol-lowering PCSK9 drug
LIB Therapeutics has scored an FDA approval for its cholesterol-lowering PCSK9 inhibitor, Lerochol, which offers a convenience edge.
Kevin Dunleavy
Dec 15, 2025 11:33am
Fierce Biotech
Merck's PCSK9 drug mounts injectable-like cholesterol reductions
Nov 10, 2025 10:59am
Amgen's Repatha meets the mark in CV primary prevention trial
Oct 2, 2025 11:26am
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Aug 8, 2025 9:32am
Carvykti, Sangon, China and more—Fierce Pharma Asia
Aug 18, 2023 9:10am
Sanofi, Regeneron clinch win in PCSK9 patent feud with Amgen
May 18, 2023 3:16pm
